Identifying the Mechanisms of Missingness for Unspecified Diabetic Retinopathy Disease Severity in the Electronic Health Record: An IRIS® Registry Analysis

Research Lead:

Mike Mbagwu, Zhongdi Chu, Durga Borka, Alex Koshta, Nisarg Shah, Aracelis Torres, Hylton Kalvaria, Flora Lum, Matthew T Roe, Theodore Leng

Abstract

Observational studies of diabetic retinopathy (DR) using electronic health record data often determine disease severity using International Classification of Disease (ICD) codes. We investigated the mechanism of missingness for DR severity based on ICD coding using the American Academy of Ophthalmology IRIS® Registry. We included all patient encounters in the registry with a DR ICD-9 or ICD-10 code between January 1, 2014 and June 30, 2021. Demographic, clinical, and practice-level characteristics were compared between encounters with specified and unspecified disease severity. Practices were divided into quartiles based on the proportion of clinical encounters with unspecified DR severity. Encounters with unspecified disease severity were associated with significantly older patient age, better visual acuity, and lower utilization of ophthalmic procedures. Higher volume practices and retina specialist practices had lower proportions of clinical encounters with unspecified disease severity. Results strongly suggest that DR disease severity related to ICD coding is missing not at random.

SUO 2025: Real-world Outcomes in Patients with BCG-unresponsive, High-risk, Non-muscle Invasive Bladder Cancer with Carcinoma in Situ – A Chart Review Study in the American Urological Association’s Quality Registry

December 16, 2025
Read More

Standalone Canaloplasty and Trabeculotomy Using the OMNI Surgical System: A Subgroup Analysis from the American Academy of Ophthalmology IRIS® Registry (Intelligent Research in Sight)

November 3, 2025
Read More

Contemporary Trends of Benign Prostatic Hyperplasia Procedures in the AUA Quality Registry: Are We Moving the Needle Toward More Minimally Invasive Treatments?

May 29, 2025
Read More

A Multifaceted Assessment of Benign Prostatic Hyperplasia Practice and AUA Guideline Adherence

May 29, 2025
Read More

Who Progresses to Third-Line Therapies for Overactive Bladder? Trends From the AQUA Registry

May 29, 2025
Read More

Choice of First Medication Prescribed For Overactive Bladder Changes With Time: Trends From The AUA AQUA Registry

May 29, 2025
Read More

Factors Influencing Medication Selection for Management of Overactive Bladder: Trends and Insights From AUA Quality Registry

May 29, 2025
Read More

Time Trends and Variation in the Use of Active Surveillance for Management of Low-risk Prostate Cancer in the US

May 29, 2025
Read More

Early Outcomes After Initiation of Faricimab for Neovascular Age-Related Macular Degeneration

May 21, 2025
Read More

How intravitreal anti-vascular endothelial growth factor initial dosing impacts patient outcomes in diabetic macular oedema”

December 13, 2024
Read More
Qdata

Talk to a Qdata Expert

Take a minute to submit your contact information and one of our team members will reach out to you.